CDC Media Relations: Press Release

ļ»?html> CDC Media Relations: Press Release


Media Relations Links
ā€?/td>	About Us
ā€?/td>	Media Contact
ā€?/td>	Frequently Asked Questions
ā€?/td>	Media Site Map
CDC News
ā€?/td>	Press Release Library
ā€?/td>	Transcripts
ā€?/td>	MMWR Summaries
ā€?/td>	B-Roll Footage
ā€?/td>	Upcoming Events
Related Links
ā€?/td>	Centers at CDC
ā€?/td>	Data and Statistics
ā€?/td>	Health Topics A-Z
ā€?/td>	Image Library
ā€?/td>	Publications, Software and Other Products
ā€?/td>	Global Health Odyssey

Find your state or local health department

HHS News

National Health Observances



Div. of Media Relations 1600 Clifton Road MS D-14 Atlanta, GA 30333 (404) 639-3286 Fax (404) 639-7394

November 1, 2001/12:00 PM, ET
Contact: CDC Media Relations
(404) 639-3286

Press Release

CDC Update: Current case count, MMWR anthrax updates, Transcript available

CDC confirmed cases of anthrax

Summary of Local, State, and Federal Confirmed Human Cases and Exposures

Case Status	Florida	New York City	New Jersey	Washington, DC	Total
Confirmed	2	4	5	5	16
Cutaneous	0	3	3	0
Inhalational	2	1	2	5
Suspect	0	4	2	0	6
Cutaneous	0	4	2	0
Inhalational	0	0	0	0
Total Cases					22

There have been 4 deaths associated with inhalational anthrax.

CDC confirmed cases are based on a rigorous case definition which was published in CDCā€™s Morbidity and Mortality Weekly Report (MMWR) on October 19, 2001. The MMWR is available on-line at: http://www.cy118119.com/mmwr/preview/mmwrhtml/mm5041a1.htm.

CDC defines a confirmed case of anthrax as 1) a clinically compatible case of cutaneous, inhalational, or gastrointestinal illness that is laboratory confirmed by isolation of B. anthracis from an affected tissue or site or 2) other laboratory evidence of B. anthracis infection based on at least two supportive laboratory tests. CDC defines a suspect case as 1) a clinically compatible case of illness without isolation of B. anthracis and no alternative diagnosis, but with laboratory evidence of B. anthracis by one supportive laboratory test or 2) a clinically compatible case of anthrax epidemiologically linked to a confirmed environmental exposure, but without corroborative laboratory evidence of B. anthracis infection.

MMWR 11-2-01: Update on Anthrax Investigations

This weekā€™s Morbidity and Mortality Weekly Report includes the article: ā€Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Clinical Evaluation of Persons with Possible Anthrax .ā€?span style="mso-spacerun: yes"> This weekā€™s issue also includes Notices to Readers regarding, ā€Updated Recommendations for Antimicrobial Prophylaxis Among Asymptomatic Pregnant Women After Exposure to Bacillus anthracisā€?and ā€Interim Recommendations for Protecting Workers from Exposure to Bacillus anthracis in Work Sites

in which Mail is Handled or Processed.ā€?span style="mso-spacerun: yes"> The MMWR is available online at www.cy118119.com/mmwr.

MMWR Anthrax website

All MMWR articles related to anthrax and bioterrorism are now archived at one location. The web address is http://www.cy118119.com/mmwr/indexbt.html.

Transcript Available

The transcript for the October 31, 2001, telebriefing on influenza with Dr. Keiji Fukuda is available online at www.cy118119.com/media/transcripts/t011031.htm.

For the latest update on CDC activities and on-going anthrax investigations visit www.bt.cdc.gov/ or www.cy118119.com/media/.

Media Home Page | Accessibility | Privacy Policy | Contact Us

CDC Home | Search | Health Topics A-Z

This page last updated November 1, 2001
URL:

United States Department of Health and Human Services
Centers for Disease Control and Prevention
Office of Communication
Division of Media Relations

¹ś²ś¾«Ę·¾Ć¾Ć¾Ć¾Ć¾ĆŅ»¼¶Ć«Ę¬